Regeneron Pharmaceuticals (REGN) Stock Chart & Stock Price History $838.20 -84.59 (-9.17%) (As of 10/31/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Regeneron Pharmaceuticals Stock Price Performance5 Day Performance-10.37%1 Month Performance-20.45%3 Month Performance-22.51%6 Month Performance-6.10%Year-To-Date Performance-4.78%1 Year Performance+7.23% Receive REGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> REGN Stock Chart for Thursday, October, 31, 2024 REGN Chart by TradingView Regeneron Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/30/2024$927.33$922.79-0.49%$935.86$914.85628,503 shs$101.73 billion10/29/2024$928.61$927.33-0.14%$932.38$924.00680,401 shs$102.23 billion10/28/2024$933.02$928.61-0.47%$943.27$927.20578,674 shs$102.37 billion10/25/2024$928.90$933.02+0.44%$943.77$930.23547,716 shs$102.86 billion10/24/2024$941.39$928.90-1.33%$952.02$928.50513,800 shs$102.40 billion10/23/2024$962.34$941.39-2.18%$959.60$932.53850,126 shs$103.78 billion Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/22/2024$968.50$962.34-0.64%$972.75$919.421.51 million shs$106.09 billion10/21/2024$990.68$968.50-2.24%$991.24$967.90793,997 shs$106.72 billion10/18/2024$998.23$990.68-0.76%$1,002.69$989.77869,179 shs$109.21 billion10/17/2024$1,007.96$998.23-0.97%$1,013.09$997.82739,679 shs$109.99 billion10/16/2024$1,016.53$1,007.96-0.84%$1,020.55$1,007.32367,108 shs$111.06 billion10/15/2024$1,014.25$1,016.53+0.22%$1,024.36$1,003.79514,379 shs$112.01 billion10/14/2024$1,015.67$1,014.25-0.14%$1,023.69$1,009.45495,567 shs$111.76 billion10/11/2024$999.02$1,015.67+1.67%$1,017.74$996.28479,889 shs$111.97 billion10/10/2024$1,012.19$999.02-1.30%$1,013.91$998.17510,884 shs$110.13 billion10/09/2024$1,005.26$1,012.19+0.69%$1,014.63$1,002.35598,061 shs$111.53 billion10/08/2024$996.05$1,005.26+0.92%$1,007.99$993.01734,291 shs$110.77 billion10/07/2024$1,012.82$996.05-1.66%$1,011.70$992.80583,417 shs$109.80 billion10/04/2024$1,014.59$1,012.82-0.17%$1,023.09$1,007.281.07 million shs$111.60 billion10/03/2024$1,040.27$1,014.59-2.47%$1,037.50$1,011.51797,495 shs$111.85 billion10/02/2024$1,046.91$1,040.27-0.63%$1,045.95$1,025.97680,321 shs$114.68 billion10/01/2024$1,051.24$1,046.91-0.41%$1,061.60$1,040.40585,563 shs$115.35 billion09/30/2024$1,042.69$1,051.24+0.82%$1,058.27$1,039.65595,485 shs$115.83 billion09/27/2024$1,039.96$1,042.69+0.26%$1,070.00$1,036.88659,538 shs$114.89 billion09/26/2024$1,031.15$1,039.96+0.85%$1,063.40$1,030.27682,712 shs$114.59 billion09/25/2024$1,045.98$1,031.15-1.42%$1,048.52$1,008.411.00 million shs$115.25 billion09/24/2024$1,091.98$1,045.98-4.21%$1,080.00$1,022.221.70 million shs$115.25 billion09/23/2024$1,145.03$1,091.98-4.63%$1,154.56$1,081.241.17 million shs$120.32 billion09/20/2024$1,150.19$1,145.03-0.45%$1,149.42$1,136.22906,225 shs$126.23 billion09/19/2024$1,138.81$1,150.19+1.00%$1,165.85$1,148.73596,670 shs$126.73 billion09/18/2024$1,146.75$1,138.81-0.69%$1,156.40$1,137.88328,053 shs$125.48 billion09/17/2024$1,153.08$1,146.75-0.55%$1,151.10$1,134.60347,697 shs$126.36 billion09/16/2024$1,153.35$1,153.08-0.02%$1,162.05$1,152.01346,864 shs$127.05 billion09/13/2024$1,164.46$1,153.35-0.95%$1,170.58$1,150.02353,579 shs$127.15 billion09/12/2024$1,141.45$1,164.46+2.02%$1,167.63$1,127.20568,919 shs$128.31 billion09/11/2024$1,136.35$1,141.45+0.45%$1,143.19$1,113.24481,944 shs$125.77 billion09/10/2024$1,144.77$1,136.35-0.74%$1,144.22$1,122.53356,458 shs$125.27 billion09/09/2024$1,131.50$1,144.77+1.17%$1,151.13$1,132.51513,283 shs$126.20 billion09/06/2024$1,150.56$1,131.50-1.66%$1,152.87$1,128.97616,624 shs$124.74 billion09/05/2024$1,179.37$1,150.56-2.44%$1,175.16$1,143.87534,235 shs$126.84 billionUnveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>>09/04/2024$1,168.81$1,179.37+0.90%$1,182.31$1,163.35333,016 shs$130.01 billion09/03/2024$1,184.69$1,168.81-1.34%$1,192.54$1,162.87532,834 shs$128.79 billion09/02/2024$1,184.69$1,184.69$1,191.33$1,170.84405,300 shs$130.54 billion08/30/2024$1,178.93$1,184.69+0.49%$1,191.33$1,170.84405,354 shs$130.54 billion08/29/2024$1,199.29$1,178.93-1.70%$1,210.97$1,175.47538,607 shs$129.90 billion08/28/2024$1,201.76$1,199.29-0.21%$1,206.26$1,190.17308,321 shs$132.14 billion08/27/2024$1,199.37$1,201.76+0.20%$1,211.20$1,197.13295,489 shs$132.42 billion08/26/2024$1,199.12$1,199.37+0.02%$1,206.81$1,196.33239,678 shs$132.15 billion08/23/2024$1,187.66$1,199.12+0.96%$1,202.24$1,190.00296,787 shs$132.19 billion08/22/2024$1,185.34$1,187.66+0.20%$1,191.84$1,180.00310,225 shs$130.93 billion08/21/2024$1,192.23$1,185.34-0.58%$1,203.49$1,184.03338,541 shs$130.61 billion08/20/2024$1,196.88$1,192.23-0.39%$1,201.59$1,185.87372,240 shs$131.37 billion08/19/2024$1,179.31$1,196.88+1.49%$1,197.69$1,178.18400,331 shs$131.88 billion08/16/2024$1,175.33$1,179.31+0.34%$1,185.09$1,166.72564,436 shs$129.94 billion08/15/2024$1,156.86$1,175.33+1.60%$1,177.95$1,155.31569,741 shs$129.50 billion08/14/2024$1,158.33$1,156.86-0.13%$1,161.21$1,138.67430,595 shs$127.53 billion08/13/2024$1,121.09$1,158.33+3.32%$1,160.46$1,122.51567,428 shs$127.63 billion08/12/2024$1,131.24$1,121.09-0.90%$1,129.99$1,109.99501,093 shs$123.53 billion08/09/2024$1,113.35$1,131.24+1.61%$1,133.00$1,111.11407,755 shs$124.65 billion08/08/2024$1,067.80$1,113.35+4.27%$1,114.90$1,069.03618,749 shs$122.68 billion08/07/2024$1,066.19$1,067.80+0.15%$1,077.09$1,061.46502,528 shs$117.66 billion08/06/2024$1,071.28$1,066.19-0.48%$1,090.78$1,064.23421,180 shs$117.48 billion08/05/2024$1,082.19$1,071.28-1.01%$1,088.83$1,051.54619,442 shs$118.04 billion08/02/2024$1,093.14$1,082.19-1.00%$1,115.00$1,071.98629,909 shs$119.25 billion08/01/2024$1,079.19$1,093.14+1.29%$1,101.20$1,041.85897,280 shs$120.45 billion07/31/2024$1,077.80$1,079.19+0.13%$1,090.84$1,073.23507,580 shs$118.92 billion07/30/2024$1,077.19$1,077.80+0.06%$1,092.46$1,066.92357,696 shs$118.76 billion Related Companies Amgen Stock Price Chart Vertex Pharmaceuticals Stock Price Chart Gilead Sciences Stock Price Chart Alnylam Pharmaceuticals Stock Price Chart Biogen Stock Price Chart BeiGene Stock Price Chart Royalty Pharma Stock Price Chart United Therapeutics Stock Price Chart Incyte Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Receive REGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:REGN) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.